MAZE Competitors & Alternatives
Compare Maze Therapeutics, Inc. Common Stock with similar stocks in the same industry
Biotechnology
MAZE
Main Stock$26.41
Tradestie Score
58
Market Cap
$1.13B
Analyst Upside
+136.8%
Top Competitors
224 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AUPH
Aurinia Pharmaceuticals Inc
|
$17.88
|
$1.50B | 8.1 | 65 | Compare |
|
GPCR
Structure Therapeutics Inc. American Depositary Shares
|
$45.61
|
$1.50B | - | 57 | Compare |
|
AMLX
Amylyx Pharmaceuticals, Inc. Common Stock
|
$16.37
|
$1.49B | - | 62 | Compare |
|
RCUS
Arcus Biosciences, Inc.
|
$28.18
|
$1.43B | - | 55 | Compare |
|
JANX
Janux Therapeutics, Inc. Common Stock
|
$14.91
|
$1.42B | - | 67 | Compare |
|
SNDX
Syndax Pharmaceuticals, Inc.
|
$19.61
|
$1.35B | - | 61 | Compare |
|
MPLT
MPLT
|
$28.64
|
$1.34B | - | 54 | Compare |
|
RAPP
Rapport Therapeutics, Inc. Common Stock
|
$38.88
|
$1.32B | - | 65 | Compare |
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$7.20
|
$1.29B | 98.6 | 67 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$31.11
|
$1.29B | - | 67 | Compare |
More MAZE Analysis
Data updated: Jun 24, 2026 | Industry: Biotechnology (SIC 2836)
224 stocks in this industry